[go: up one dir, main page]

CL2007001686A1 - Composicion farmaceutica estable en aerosol de un agonista beta, un anticolinergico o una combinacion de los mismos con un cosolvente y opcionalmente un surfactante; metodo de preparacion y su uso para tratar broncoconstriccion, broncoespasmo, asma y - Google Patents

Composicion farmaceutica estable en aerosol de un agonista beta, un anticolinergico o una combinacion de los mismos con un cosolvente y opcionalmente un surfactante; metodo de preparacion y su uso para tratar broncoconstriccion, broncoespasmo, asma y

Info

Publication number
CL2007001686A1
CL2007001686A1 CL200701686A CL2007001686A CL2007001686A1 CL 2007001686 A1 CL2007001686 A1 CL 2007001686A1 CL 200701686 A CL200701686 A CL 200701686A CL 2007001686 A CL2007001686 A CL 2007001686A CL 2007001686 A1 CL2007001686 A1 CL 2007001686A1
Authority
CL
Chile
Prior art keywords
polinergic
broncoconstriction
bronchospasm
cosolvent
asthma
Prior art date
Application number
CL200701686A
Other languages
English (en)
Inventor
Sawant Danilo Parab Rajesh
Original Assignee
Medispray Lab Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38510317&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2007001686(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Medispray Lab Pvt Ltd filed Critical Medispray Lab Pvt Ltd
Publication of CL2007001686A1 publication Critical patent/CL2007001686A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CL200701686A 2006-06-12 2007-06-11 Composicion farmaceutica estable en aerosol de un agonista beta, un anticolinergico o una combinacion de los mismos con un cosolvente y opcionalmente un surfactante; metodo de preparacion y su uso para tratar broncoconstriccion, broncoespasmo, asma y CL2007001686A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN918MU2006 2006-06-12

Publications (1)

Publication Number Publication Date
CL2007001686A1 true CL2007001686A1 (es) 2008-03-14

Family

ID=38510317

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200701686A CL2007001686A1 (es) 2006-06-12 2007-06-11 Composicion farmaceutica estable en aerosol de un agonista beta, un anticolinergico o una combinacion de los mismos con un cosolvente y opcionalmente un surfactante; metodo de preparacion y su uso para tratar broncoconstriccion, broncoespasmo, asma y

Country Status (13)

Country Link
US (2) US20070286814A1 (es)
EP (1) EP2040670A1 (es)
JP (1) JP2009539958A (es)
KR (1) KR20090033355A (es)
AU (1) AU2007259064A1 (es)
BR (1) BRPI0711688A2 (es)
CA (1) CA2654041A1 (es)
CL (1) CL2007001686A1 (es)
MX (1) MX2008015589A (es)
PE (1) PE20080204A1 (es)
RU (1) RU2009100156A (es)
WO (1) WO2007144604A1 (es)
ZA (1) ZA200810142B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8425459B2 (en) 2006-11-20 2013-04-23 Lutonix, Inc. Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent
US8414526B2 (en) 2006-11-20 2013-04-09 Lutonix, Inc. Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids
US8998846B2 (en) 2006-11-20 2015-04-07 Lutonix, Inc. Drug releasing coatings for balloon catheters
US8414525B2 (en) * 2006-11-20 2013-04-09 Lutonix, Inc. Drug releasing coatings for medical devices
US9737640B2 (en) 2006-11-20 2017-08-22 Lutonix, Inc. Drug releasing coatings for medical devices
US8414910B2 (en) 2006-11-20 2013-04-09 Lutonix, Inc. Drug releasing coatings for medical devices
US20080276935A1 (en) 2006-11-20 2008-11-13 Lixiao Wang Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs
US9700704B2 (en) 2006-11-20 2017-07-11 Lutonix, Inc. Drug releasing coatings for balloon catheters
US8414909B2 (en) 2006-11-20 2013-04-09 Lutonix, Inc. Drug releasing coatings for medical devices
WO2010024898A2 (en) 2008-08-29 2010-03-04 Lutonix, Inc. Methods and apparatuses for coating balloon catheters
US20130160761A1 (en) * 2008-11-04 2013-06-27 Cipla Limited Pharmaceutical Aerosol Composition
ES2628891T3 (es) * 2010-08-03 2017-08-04 Chiesi Farmaceutici S.P.A. Formulación farmacéutica que comprende un inhibidor de fosfodiesterasa
TWI399202B (zh) * 2011-03-17 2013-06-21 Intech Biopharm Ltd 製備用於治療呼吸道疾病之定量噴霧吸入劑的製程方法
EP3174522A1 (en) * 2014-07-29 2017-06-07 3M Innovative Properties Company Method of preparing a pharmaceutical composition
WO2016164508A1 (en) * 2015-04-10 2016-10-13 3M Innovative Properties Company Formulation and aerosol canisters, inhalers, and the like containing the formulation
WO2016170518A1 (en) 2015-04-24 2016-10-27 Glenmark Specialty S.A. Pharmaceutical compositions comprising arformoterol and glycopyrronium
US10231948B2 (en) 2017-02-27 2019-03-19 Jason Ty Nguyen Metered dose inhaler compositions, systems, and methods
BR112020026957A2 (pt) * 2018-06-29 2021-03-30 Csp Technologies, Inc. Polímero dessecante de inalador de baixo odor ou sem odor
NL2036216B1 (en) * 2023-11-08 2025-05-19 Jove Beheer B V Water drainage system for draining water into an aquifer

Family Cites Families (96)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE555319A (es) * 1956-03-21 1900-01-01
US2885427A (en) * 1956-11-15 1959-05-05 Dow Chemical Co Fluorination of trichloroethylene
BE556587A (es) * 1957-01-31 1957-04-11
US3095355A (en) * 1961-10-12 1963-06-25 Revlon Aerosol composition
BE629985A (es) * 1962-11-29
US3250808A (en) * 1963-10-31 1966-05-10 Du Pont Fluorocarbon ethers derived from hexafluoropropylene epoxide
US3261748A (en) * 1964-07-17 1966-07-19 Dow Chemical Co 1,1,1,2-tetrafluoroethane anesthetic
GB1114313A (en) * 1964-11-19 1968-05-22 Wyeth John & Brother Ltd Pharmaceutical compositions
GB1200886A (en) * 1966-09-23 1970-08-05 Allen & Hanburys Ltd Phenylaminoethanol derivatives
US3551558A (en) * 1967-08-18 1970-12-29 Eisai Co Ltd Therapeutical aerosol composition and preparation thereof
US3505337A (en) * 1967-12-22 1970-04-07 Boehringer Sohn Ingelheim N - hydrocarbyl-substituted noratropinium,haloalkylates and o-acyl derivatives thereof
US4143204A (en) * 1971-12-27 1979-03-06 E. I. Du Pont De Nemours And Company Articles coated with fluorocarbon resins
US3994974A (en) * 1972-02-05 1976-11-30 Yamanouchi Pharmaceutical Co., Ltd. α-Aminomethylbenzyl alcohol derivatives
GB1429184A (en) * 1972-04-20 1976-03-24 Allen & Hanburys Ltd Physically anti-inflammatory steroids for use in aerosols
US4044126A (en) * 1972-04-20 1977-08-23 Allen & Hanburys Limited Steroidal aerosol compositions and process for the preparation thereof
US4025635A (en) * 1972-09-06 1977-05-24 Burroughs Wellcome Co. Cyclic sulphur compounds
US4011661A (en) * 1973-10-30 1977-03-15 Kyowa Hakko Kogyo Co., Ltd. Powdered emulsion product and method of production
US3987192A (en) * 1974-01-07 1976-10-19 The Upjohn Company Compositions and process of treatment
US4405598A (en) * 1976-01-30 1983-09-20 Fisons, Limited Composition for treating asthma
NL7708731A (nl) * 1976-08-13 1978-02-15 Montedison Spa Werkwijze voor de bereiding van nieuwe drijf- middelsamenstellingen voor aerosolen.
US4129603A (en) * 1978-02-07 1978-12-12 Imperial Chemical Industries Limited Manufacture of halogenated compounds
DE2903957A1 (de) * 1979-02-02 1980-08-07 Boehringer Sohn Ingelheim Mittel zur behandlung der nasalen hypersekretion
DE3013839A1 (de) * 1979-04-13 1980-10-30 Freunt Ind Co Ltd Verfahren zur herstellung einer aktivierten pharmazeutischen zusammensetzung
US4352789A (en) * 1980-03-17 1982-10-05 Minnesota Mining And Manufacturing Company Aerosol compositions containing finely divided solid materials
EP0072046B1 (en) * 1981-07-24 1986-01-15 FISONS plc Inhalation drugs, methods for their production and pharmaceutical formulations containing them
US4476130A (en) * 1982-09-09 1984-10-09 Riker Laboratories, Inc. 3-(1H-Tetrazol-5-yl)-4H-pyrimido[2,1-b]benzoxazol-4-one compounds exhibiting anti-allergic activity
ZW6584A1 (en) * 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
US4671270A (en) * 1984-07-06 1987-06-09 Midori Anzen Industry Co., Ltd. Portable oxygen inhaler
US4621116A (en) * 1984-12-07 1986-11-04 E. I. Du Pont De Nemours And Company Process for copolymerization of tetrafluoroethylene in the presence of a dispersing agent comprising a perfluoroalkoxybenzene sulfonic acid or salt
GB8432063D0 (en) * 1984-12-19 1985-01-30 Riker Laboratories Inc Physically modified steroids
GB8501015D0 (en) * 1985-01-16 1985-02-20 Riker Laboratories Inc Drug
EP0223831B1 (en) * 1985-05-22 1992-07-15 Liposome Technology, Inc. Liposome inhalation method and system
WO1987005211A1 (fr) * 1986-03-10 1987-09-11 Kurt Burghart Preparation pharmaceutique et son procede de production
JP2573275B2 (ja) * 1986-03-10 1997-01-22 ブルグハルト，クルト 薬学的製剤及びその製造法
US5093403A (en) * 1986-07-01 1992-03-03 Edlon Products, Inc. Polymer-metal bonded composite and method of producing same
US5536583A (en) * 1986-07-01 1996-07-16 Edlon Products, Inc. Polymer metal bonded composite and method of producing same
US4819834A (en) * 1986-09-09 1989-04-11 Minnesota Mining And Manufacturing Company Apparatus and methods for delivering a predetermined amount of a pressurized fluid
DE3778324D1 (de) * 1986-12-01 1992-05-21 Tokuyama Soda Kk Verfahren zur herstellung von organischen perfluoro-verbindungen.
US4752466A (en) * 1987-08-31 1988-06-21 Johnson & Johnson Products, Inc. Thrombin aerosol
US4889656A (en) * 1987-10-30 1989-12-26 Minnesota Mining And Manufacturing Company Perfluoro(cycloaliphatic methyleneoxyalkylene) carbonyl fluorides and derivatives thereof
US4834083A (en) * 1988-05-12 1989-05-30 Minnesota Mining And Manufacturing Company Aerosol device
FI894611L (fi) * 1988-09-30 1990-03-31 May & Baker Ltd Granulaera farmaceutiska preparat.
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
US4906476A (en) * 1988-12-14 1990-03-06 Liposome Technology, Inc. Novel liposome composition for sustained release of steroidal drugs in lungs
GB8909891D0 (en) * 1989-04-28 1989-06-14 Riker Laboratories Inc Device
FR2649359B1 (fr) * 1989-07-06 1993-02-12 Cebal Bande ou portion de bande pour emboutissage ou emboutissage-etirage, et son utilisation
GB8917285D0 (en) * 1989-07-28 1989-09-13 Harris Pharma Ltd A valve for an aerosol dispenser
US5208226A (en) * 1989-09-08 1993-05-04 Glaxo Group Limited Medicaments
US5439670A (en) * 1989-11-28 1995-08-08 Riker Laboratories, Inc. Medicinal aerosol formulations
GB9001635D0 (en) * 1990-01-24 1990-03-21 Ganderton David Aerosol carriers
US5376386A (en) * 1990-01-24 1994-12-27 British Technology Group Limited Aerosol carriers
US5062423A (en) * 1990-02-27 1991-11-05 Minnesota Mining And Manufacturing Company Equine aerosol drug delivery method and apparatus
US5118494A (en) * 1990-03-23 1992-06-02 Minnesota Mining And Manufacturing Company Use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
US5126123A (en) * 1990-06-28 1992-06-30 Glaxo, Inc. Aerosol drug formulations
US5223343A (en) * 1990-12-12 1993-06-29 E. I. Du Pont De Nemours And Company Non-stick coating system with high and low melt viscosity PTFE for concentration gradient
US5190029A (en) * 1991-02-14 1993-03-02 Virginia Commonwealth University Formulation for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
US5182097A (en) * 1991-02-14 1993-01-26 Virginia Commonwealth University Formulations for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
SE9302777D0 (sv) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
SE9101090D0 (sv) * 1991-04-11 1991-04-11 Astra Ab Process for conditioning of water-soluble substances
EP0656206B1 (en) * 1991-06-10 2001-08-08 Schering Corporation Non-chlorofluorocarbon aerosol formulations
US6123924A (en) * 1991-09-25 2000-09-26 Fisons Plc Pressurized aerosol inhalation compositions
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
US5653962A (en) * 1991-12-12 1997-08-05 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
GB9200148D0 (en) * 1992-01-06 1992-02-26 Minnesota Mining & Mfg Aerosol valves
GB9202519D0 (en) * 1992-02-06 1992-03-25 Glaxo Group Ltd Medicaments
DE69306379T2 (de) * 1992-03-10 1997-06-12 Fisons Plc Inhalierbare arzneimittel
DE4230876A1 (de) * 1992-03-17 1993-09-23 Asta Medica Ag Druckgaspackungen unter verwendung von polyoxyethylen-glyceryl-oleaten
DE59309257D1 (de) * 1992-10-26 1999-02-11 Sanol Arznei Schwarz Gmbh Verfahren zur herstellung von mikrokapseln
EP0689424B1 (en) * 1993-03-17 1998-10-14 Minnesota Mining And Manufacturing Company Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid
US5492688A (en) * 1993-04-28 1996-02-20 The Center For Innovative Technology Metered dose inhaler fomulations which include the ozone-friendly propellant HFC 134a and a pharmaceutically acceptable suspending, solubilizing, wetting, emulsifying or lubricating agent
US5348731A (en) * 1993-05-19 1994-09-20 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Aerosol spray steel can dispensers with corrosion inhibitors
DE4329446A1 (de) * 1993-09-01 1995-03-02 Basf Ag Verfahren zur Herstellung von feinteiligen Farb- oder Wirkstoffzubereitungen
ATE233544T1 (de) * 1993-12-02 2003-03-15 Abbott Lab Aerosole als darreichungsform mit cfc-freiem treibmittel
US5467900A (en) * 1994-03-16 1995-11-21 Afa Products, Inc. Precompression valve for trigger sprayer
US5508023A (en) * 1994-04-11 1996-04-16 The Center For Innovative Technology Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
GB9420971D0 (en) * 1994-05-06 1994-12-07 Minnesota Mining & Mfg Aerosol valves
DE4427175A1 (de) * 1994-08-01 1996-02-08 Coster Tecnologie Speciali Spa Baueinheit
US5647347A (en) * 1994-10-21 1997-07-15 Glaxo Wellcome Inc. Medicament carrier for dry powder inhalator
US5534270A (en) * 1995-02-09 1996-07-09 Nanosystems Llc Method of preparing stable drug nanoparticles
US5653961A (en) * 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
US5612053A (en) * 1995-04-07 1997-03-18 Edward Mendell Co., Inc. Controlled release insufflation carrier for medicaments
CA2217950C (en) * 1995-04-14 2001-12-25 Glaxo Wellcome Inc. Metered dose inhaler for albuterol
US5667806A (en) * 1995-06-07 1997-09-16 Emisphere Technologies, Inc. Spray drying method and apparatus
US5603918A (en) * 1995-06-09 1997-02-18 Boehringer Ingelheim Pharmaceuticals, Inc. Aerosol composition of a salt of ipratropium and a salt of albuterol
AU759222B2 (en) * 1998-06-18 2003-04-10 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical formulations for aerosols with two or more active substances
US6315985B1 (en) * 1999-06-18 2001-11-13 3M Innovative Properties Company C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
GB0008485D0 (en) * 2000-04-07 2000-05-24 Glaxo Group Ltd Pharmaceutical compositions
HU230804B1 (hu) * 2000-05-22 2018-06-28 Chiesi Farmaceutici S.P.A Gyógyászati célú stabil aeroszol összetétel, inhalátor az aeroszol pontos adagolásához és eljárás ennek feltöltésére
GB0106046D0 (en) * 2001-03-12 2001-05-02 Glaxo Group Ltd Canister
US20030018019A1 (en) * 2001-06-23 2003-01-23 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
US8962601B2 (en) * 2002-08-29 2015-02-24 Cipla Ltd Pharmaceutical products and composition comprising specific anticholinergic agents, β-2 agonists and corticosteroids
DK1809243T4 (da) * 2004-07-02 2022-09-05 Boehringer Ingelheim Int Aerosolsuspensionsformuleringer med tg 227 ea som drivmiddel
US20060079544A1 (en) * 2004-08-13 2006-04-13 Boehringer Ingelheim International Gmbh Medicaments for the prevention or treatment of alveolar pneumonia comprising an anticholinergic
JP2008512434A (ja) * 2004-09-09 2008-04-24 シプラ・リミテッド ベータ擬似剤の異性体及び抗コリン作用剤を含む医薬組成物

Also Published As

Publication number Publication date
US20090191134A1 (en) 2009-07-30
WO2007144604A1 (en) 2007-12-21
MX2008015589A (es) 2009-03-20
JP2009539958A (ja) 2009-11-19
BRPI0711688A2 (pt) 2012-01-17
RU2009100156A (ru) 2010-07-20
ZA200810142B (en) 2009-11-25
CA2654041A1 (en) 2007-12-21
EP2040670A1 (en) 2009-04-01
AU2007259064A1 (en) 2007-12-21
PE20080204A1 (es) 2008-04-11
US20070286814A1 (en) 2007-12-13
KR20090033355A (ko) 2009-04-02

Similar Documents

Publication Publication Date Title
CL2007001686A1 (es) Composicion farmaceutica estable en aerosol de un agonista beta, un anticolinergico o una combinacion de los mismos con un cosolvente y opcionalmente un surfactante; metodo de preparacion y su uso para tratar broncoconstriccion, broncoespasmo, asma y
BRPI0911273A2 (pt) inibidor de dpp-iv combinado com outro agente antidiabético, comprimidos que compreendem tais formulações, seu uso e processo para sua preparação
CL2007003203A1 (es) Composicion que comprende acido rosmarinico y/o derivados de este en combinacion con una enzima hidrolitica y/o con un microorganismo que contiene o produce dicha enzima; metodo de preparacion; y su uso como cosmetico y para prevenir los danos en la
BRPI0720124A2 (pt) Composições farmacêuticas e seus métodos de uso.
BRPI0617159A2 (pt) COMPOSTOS DE PIRIDOPIRIMIDINONE INIBIDORES DE PI3Ka, COMPOSIÇÕES QUE OS CONTEM E PROCESSO PARA PREPARO
BRPI0816256A2 (pt) Uso de hidrofobina, e, processo para a preparação de um agente para a absorção melhorada de substâncias ativas no uso tópico
BRPI0815360A2 (pt) Composto derivado de 4-pirimidinossulfamida, composição farmacêutica que o contem, uso e processo para pa preparação do composto
BRPI0918359A2 (pt) composto, composição agroquímica, uso da composição agroquímica e método para preparação do composto
BRPI0916630A2 (pt) composições para uso em construção e processo de aplicação das mesmas
BRPI0920383A2 (pt) método para minimizar o diâmetro de uma solução de uréia, solução de uréia e uso de um tensoativo em solução de uréia
CL2011000851A1 (es) Composicion farmaceutica que comprende al menos una insulina y al menos un agonista de glp-1; metodo de preparacion; su uso para tratar diabetes o prevenir la disfuncion de celulas beta pancreaticas; kit; y dispositivo.
MX2008006583A (es) Composiciones de edulcorante natural de alta potencia, con perfil de sabor y/o perfil temporal mejorado, metodos para su formulacion, y usos
BRPI0822104A2 (pt) Composições antimicrobianas e métodos para o uso das mesmas
CL2007001976A1 (es) Compuestos derivados de dioxoalcanos y dioxoalquenos; procedimiento de preparacion; composicion farmaceutica; y su uso para tratar asma, tos, purito, hipersensibilidad.
ITMI20051347A1 (it) Estratti di cynara scolimus loro uso e formulazioni che li contengono
BRPI0807718A2 (pt) Composições de enzima digestiva estável, forma de dosagem, embalagem, uso e processo de preparação das referidas composições
BRPI0716495A2 (pt) (r,r)-fenoterol e análogos de (r,r)- ou (r,s)-fenoterol, uso dos mesmos na preparação de composição farmacêutica e composição farmacêutica compreendendo o referidos compostos.
CL2008000063A1 (es) Microcapsula que comprende una aglomeracion de microcapsulas primarias y una sustancia de carga; proceso de preparacion; y su uso para entregar una sustancia de carga a un sujeto.
CR8642A (es) Compuestos, composiciones farmaceuticas y metodos para su uso en el tratameinto de desordenes metabolicos
ITRM20040352A1 (it) Derivati oligomerici dello spirobifluorene, loro preparazione e loro uso.
BRPI0911297A2 (pt) composição e métodos para preparo e uso das mesmas
CL2007002523A1 (es) Un sistema de suministro de farmaco gastro-retentivo para suministrar valsartan que comprende a) una porcion de liberacion que comprende valsartan y b) una porcion gastro-retentiva que se puede hinchar; procedimiento de preparacion; y uso para tratar
BRPI0908882A2 (pt) combinação de ingredientes ativos e seus uso
BRPI0816389A2 (pt) Composições de celulase total fúngica filamentosa realçada por beta-glicosidade e métodos de uso
BRPI0717699A2 (pt) "composição e seus processos de preparação, uso de uma composição e uso coméstico de uma composição!